Reversal by [d-Ala 2 ,d-Leu 5 ]enkephalin of the dopamine transporter loss caused by methamphetamine

By Tsao L.-I.   Cadet J.L.   Su T.-P.  

European Journal of Pharmacology, Vol. 372, Iss. 3, 1999-05 ,pp. : 5-7

Elsevier

Access to resources Recommend Favorite

Chronic [d-Ala 2 , d-Leu 5 ]enkephalin treatment increases the nerve growth factor in adult mouse brain

By Hayashi T.   Su T.-P.  

European Journal of Pharmacology, Vol. 464, Iss. 2, 2003-03 ,pp. : 237-239

Elsevier

Access to resources Recommend Favorite

Selective antagonism by naloxonazine of antinociception by Tyr-d-Arg-Phe- -Ala, a novel dermorphin analogue with high affinity at -opioid receptors

By Sakurada S.   Takeda S.   Sato T.   Hayashi T.   Yuki M.   Kutsuwa M.   Tan-No K.   Sakurada C.   Kisara K.   Sakurada T.  

European Journal of Pharmacology, Vol. 395, Iss. 2, 2000-04 ,pp. : 107-112

Elsevier

Access to resources Recommend Favorite

Stability, metabolism and transport of d-Asp(OBzl)-Ala - a model prodrug with affinity for the oligopeptide transporter

By Steffansen B.   Lepist E.-I.   Taub M.E.   Larsen B.D.   Frokjaer S.   Lennernas H.  

European Journal of Pharmaceutical Sciences, Vol. 8, Iss. 1, 1999-04 ,pp. : 67-73

Elsevier

Access to resources Recommend Favorite

Enzymatic and permeation barrier of [d-Ala 2 ]-Met-enkephalinamide in the anterior membranes of the albino rabbit eye

By Hamalainen K.M.   Ranta V.-P.   Auriola S.   Urtti A.  

European Journal of Pharmaceutical Sciences, Vol. 9, Iss. 3, 2000-01 ,pp. : 265-270

Elsevier

Access to resources Recommend Favorite